MSDS

COMMON NAME: DIPROPYLENE GLYCOL DIBENZOATE
CAS NUMBER: 27138-31-4
CARCINOGENICITY LISTED BY: NTP NO IARC NO OSHA NO ACGIH NO
LD50: > 2000.00 MG/KG SKN RBT
LD50: 4673.00 MG/KG ORL RAT
LC50: > 200.00 GM/M3/4HR IHL RAT
SUPPLEMENTAL HEALTH INFORMATION
THE MANUFACTURER OF DIPROPYLENE GLYCOL DIBENZOATE CONDUCTED TOXICITY
TESTS AND FOUND DECREASED BODY WEIGHT GAIN, AND BLOOD, LIVER AND CAECUM
EFFECTS IN RATS GIVEN UP TO 2500 MG/KG/DAY IN THE DIET FOR 13 WEEKS. ALL
TREATMENT RELATED CHANGES SHOWED EVIDENCE OF, OR COMPLETE, RECOVERY
AFTER 4 WEEKS WITHOUT TREATMENT. RELEVANCE TO HUMANS IS UNKNOWN.
CARCINOGENICITY: CONTAINS CRYSTALLINE SILICA WHICH IS CONSIDERED A
HAZARD BY INHALATION. IARC HAS CLASSIFIED
CRYSTALLINE SILICA AS CARCINOGENIC TO HUMANS
(GROUP 1). CRYSTALLINE SILICA IS ALSO A KNOWN CAUSE
OF SILICOSIS, A NONCANCEROUS LUNG DISEASE. THE
NATIONAL TOXICOLOGY PROGRAM (NTP) HAS CLASSIFIED
CRYSTALLINE SILICA AS A KNOWN HUMAN CARCINOGEN.
IN A LIFETIME INHALATION STUDY, EXPOSURE TO 250
MG/M3 TITANIUM DIOXIDE RESULTED IN THE
DEVELOPMENT OF LUNG TUMORS IN RATS. THESE TUMORS
OCCURRED ONLY AT DUST LEVELS THAT OVERWHELMED
THE ANIMALS' LUNG CLEARANCE MECHANISMS AND WERE
DIFFERENT FROM COMMON HUMAN LUNG TUMORS IN
BOTH TYPE AND LOCATION. THE RELEVANCE OF THESE
FINDINGS TO HUMANS IS UNKNOWN BUT QUESTIONABLE.
THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
(IARC) HAS CLASSIFIED TITANIUM DIOXIDE AS POSSIBLY
CARCINOGENIC TO HUMANS (GROUP 2B) BASED ON
INADEQUATE EVIDENCE OF CARCINOGENICITY IN HUMANS
AND SUFFICIENT EVIDENCE OF CARCINOGENICITY IN
EXPERIMENTAL ANIMALS.
REPRODUCTIVE EFFECTS: NO REPRODUCTIVE EFFECTS ARE ANTICIPATED
MUTAGENICITY: NO MUTAGENIC EFFECTS ARE ANTICIPATED
TERATOGENICITY: NO TERATOGENIC EFFECTS ARE ANTICIPATED
SECTION 12: ECOLOGICAL INFORMATION
NO ECOLOGICAL TESTING HAS BEEN DONE BY AKZO NOBEL PAINTS LLC
ON THIS PRODUCT AS A WHOLE.
SECTION 13: DISPOSAL CONSIDERATIONS
WASTE DISPOSAL: DISPOSE IN ACCORDANCE WITH ALL APPLICABLE REGULATIONS.